| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $15.0M | +51.2% |
| Cost of Revenue | $5.0M | -30.0% |
| Gross Profit | $3.4M | +22.1% |
| R&D Expense | $65K | +0.0% |
| SG&A Expense | $8.3M | -63.6% |
| Operating Income | -$6.4M | +70.7% |
| Pre-tax Income | -$15.6M | +38.1% |
| Net Income | -$15.6M | +78.0% |
| EPS (Basic) | -$32.44 |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230K | +13.7% |
| Short-term Investments | $16.5M | — |
| Accounts Receivable | $274K | -31.5% |
| Inventory | $1.6M | -49.6% |
| Current Assets | $19.6M | +293.1% |
| Total Assets | $21.6M | +204.2% |
| Current Liabilities | $12.0M | -49.4% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | +52.8% |
| Investing Cash Flow | -$16.5M | — |
| Financing Cash Flow | $19.5M | +234.6% |
| -410.1% |
| EPS (Diluted) | -$32.44 | -410.1% |
| Total Liabilities |
| $12.0M |
| -53.3% |
| Stockholders' Equity | $9.6M | +151.6% |